Wealth Alliance Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Wealth Alliance Advisory Group's LLY Position: Q3 2026 in Review
Wealth Alliance Advisory Group increased its Eli Lilly (LLY) stake by 2.5% in Q3 2026, buying an estimated $189K and bringing the position to 6,445 shares worth $7.46M. The position accounts for 1.05% of the portfolio, ranked #25.
Wealth Alliance Advisory Group first reported a position in LLY in Q4 2019 and has held it in 28 quarters since. The position peaked at $7.54M in Q2 2026. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Wealth Alliance Advisory Group held 6,445 shares of Eli Lilly worth $7.46M as of Q3 2026.
- Wealth Alliance Advisory Group bought 160 Eli Lilly shares in Q3 2026, an estimated $189K.
- Eli Lilly made up 1.05% of Wealth Alliance Advisory Group's portfolio in Q3 2026, its #25 holding.
- Wealth Alliance Advisory Group first reported a position in Eli Lilly in Q4 2019 and has held it in 28 quarters since.
- Wealth Alliance Advisory Group's Eli Lilly position peaked at $7.54M in Q2 2026.
- 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Wealth Alliance Advisory Group's 13F filing for Q3 2026, filed 14 Oct 2026.